INTRODUCTION
============

The formin family of proteins plays a major role in regulating the actin cytoskeleton and is required for diverse cellular processes including cytokinesis, polarized growth, filopodia assembly, and cell--cell adhesion. Formins promote the assembly of linear actin filaments through barbed-end binding of their formin homology 1 and 2 (FH1 and FH2) domains ([@B18]; [@B27]). Diaphanous-related formins (DRFs) are typically regulated by autoinhibition, by which their N-terminal Diaphanous inhibitory domain (DID) binds their C-terminal Diaphanous autoregulatory domain (DAD; [@B41]; [@B30]). Current models suggest that autoinhibition can be relieved by binding of Rho-family GTPases at the Rho-binding domain (RBD), which is adjacent to the DID domain ([@B42]; [@B62]). However, in vitro and in vivo data suggest that Rho-GTPases are not sufficient for the complete activation of formins ([@B41]; [@B48]). Other components that cooperate with Rho to activate formins have been identified in vivo. For example, the fission yeast formin For3 requires both Cdc42 and Bud6 for complete activity in vivo ([@B48]); mDia2 is activated by Rho kinase in combination with RhoA ([@B64]). In contrast, some formins are autoinhibited but are activated by proteins other than Rho-GTPases; for example, Daam1 is activated, at least in part, by the binding of Dishevelled to the DAD domain ([@B43]). Therefore knowledge of how DRFs are regulated is incomplete.

Formins not only are important for regulating actin assembly in cells, but they are also implicated in other aspects of cytoskeletal dynamics ([@B13]; [@B47]). Some formins bind and stabilize microtubules and are required for centrosome positioning in polarized cells ([@B6]; [@B5]; [@B2]). In budding yeast, genetic experiments suggest that formins are required for the normal assembly of the septin scaffold at the bud neck ([@B34]; [@B25]). Septins are a highly conserved family of GTPases required for cytokinesis and other processes in fungal and animal cells ([@B68]). In budding yeast, septins create a scaffold at the bud neck for the recruitment of an assortment of proteins involved in cytokinesis and polarized growth ([@B20]; [@B49]). In addition to their scaffolding functions, septins establish membrane diffusion barriers and thus define specific membrane domains ([@B52]). Although increasing evidence suggests intimate associations between the actin and septin cytoskeletons, the molecular basis for these interactions and their functional role is not well understood.

The budding yeast *Saccharomyces cerevisiae* is a useful experimental system in which to study formins and formin--septin interactions. Unlike animal cells, which contain numerous formin isoforms, budding yeast has only two formins, Bni1 and Bnr1 ([@B27]; [@B10]; [@B13]). Our lab and others developed conditional strains in which formin function can be rapidly inactivated (within ∼5 min). Mutant analysis showed that budding yeast formins are required for actin cable assembly and, therefore, the control of polarized morphogenesis ([@B17]; [@B55]; [@B60], [@B61]). Budding yeast formins are also required for spindle positioning (via their role in actin cable assembly; [@B39]) and the assembly of the cytokinetic actomyosin ring ([@B65]; [@B56]; [@B69]). Although individually Bni1 and Bnr1 are not essential, deletion of both formins is lethal ([@B38]; [@B31]; [@B53]). Two pieces of evidence suggest that Bnr1 is regulated by autoinhibition. First, the lethality of a *rho3Δ rho4Δ* double-deletion strain can be rescued by deletion of the RBD of Bnr1 ([@B16]). Second, deletion of the DAD domain of Bnr1 generates an actin cable defect, consistent with the generation of excess actin filaments ([@B12]). Although the RBD is clearly required to inhibit Bnr1, the identification of the relevant Rho-type GTPase is less clear. There is evidence to suggest that Bnr1 interacts with Rho4-GTP ([@B35]); however, there is no obvious growth or actin assembly defect in a *rho4Δ bni1Δ* strain ([@B16]; our unpublished results). Taken together, these results suggest that Bnr1 is likely autoinhibited, but the relevant Rho-GTPase has not been identified, and it is not known whether other regulators are required. Therefore we investigated other proteins that are required for the assembly of actin cables by Bnr1.

Bnr1 localizes to the bud neck at the onset of bud emergence and remains there until cytokinesis ([@B37]; [@B9]). This bud neck localization is entirely dependent on septins ([@B56]; [@B23]). Recent results showed that Bnr1 has two distinct localization signals that both require an intact septin cytoskeleton: the L1 domain is required for the spatial restriction of Bnr1 to the mother side of the bud neck (mother-side bias), and the L2 domain is required for the normal cell cycle timing of Bnr1 localization to the bud neck (i.e., its recruitment at bud emergence and loss at septin ring splitting; [@B23]). However, the binding partners of these domains are unknown; it is also unclear whether Bnr1 interacts directly with septins or indirectly with other components of the septin scaffold, such as the septin-associated kinases Elm1 and Gin4. In general, the relationship between the localization of Bnr1 and its function in the assembly of actin cables is unclear.

Here we present evidence that the septin-associated microtubule-affinity regulating kinase (MARK)/Par1-family kinase Gin4 is required for the localization of Bnr1 to the bud neck, as well as for its ability to promote actin assembly in yeast. A structure--function analysis suggests that Gin4 recruits Bnr1 to the bud neck in a manner that requires the Bnr1 L2 domain. The recruitment of Bnr1 is independent of the Gin4 N-terminal kinase domain, and the Gin4 C-terminus binds the minimal localization domain (N-terminus) of Bnr1. We also define an unexpected role for the septin Shs1 in regulating Bnr1. There are five septins in budding yeast: Cdc3, Cdc10, Cdc11, Cdc12, and Shs1. Shs1 is nonessential; its deletion results in defects in the septin cytoskeleton ([@B11]; [@B24]). Unlike Gin4, Shs1 is not required for Bnr1 localization. However, in common with the loss of Gin4, the deletion of Shs1 causes a striking defect in Bnr1-dependent actin cable assembly. Taken together, these data define novel regulatory links between the septin and actin cytoskeletons. We speculate that Gin4 and Shs1 may activate Bnr1 by a novel regulatory mechanism.

RESULTS
=======

Partial requirement for the septin-associated proteins Gin4 and Elm1 for the bud neck localization of full-length Bnr1
----------------------------------------------------------------------------------------------------------------------

Bnr1 localizes to the bud neck at the onset of bud emergence with a bias toward the mother side of the bud neck. Bnr1 remains at the bud neck until mitotic exit, when it is dispersed at the time of septin ring splitting ([@B37]; [@B9]; [@B23]). The bud neck localization of Bnr1 is dependent on an intact septin scaffold ([@B56]). To identify candidate bud neck receptors for Bnr1, we examined strains lacking specific septins (Shs1) or septin-associated proteins (Gin4, Elm1, and Nap1) for defects in Bnr1 localization ([@B11]; [@B44]; [@B26]). Shs1 is the nonessential septin in budding yeast; deletion of Shs1 results in defects in the septin cytoskeleton ([@B11]; [@B24]). Gin4 and Elm1 are septin-associated kinases that, when deleted, result in varying degrees of septin defects, which are exacerbated at higher temperatures ([@B44]; [@B7]; [@B26]). Deletion of Nap1, an upstream activator of Gin4 ([@B1]), shows aberrant septin staining similar to a *gin4Δ* strain ([@B26]).

We compared endogenous level Bnr1--green fluorescent protein (GFP) localization to that of endogenous level Myo1--cyan fluorescent protein (CFP), the type II myosin in budding yeast, which also requires septins for its localization the bud neck. Myo1 specifically depends on Shs1, Bni5, and Iqg1 for localization ([@B19]). We imaged fixed cells at 24°C (Supplemental Figure S1) or after a temperature shift of 4 h at 37°C. We found that both Elm1 and Gin4 are required for the normal localization of Bnr1. In strains lacking Elm1 or Gin4, the fraction of Myo1-CFP--positive cells with Bnr1-GFP at the bud neck was diminished; this phenotype was more prominent at 37°C ([Figure 1, A and B](#F1){ref-type="fig"}, and Supplemental Figure S1, A and B). By contrast, the localization of Myo1 was unaffected in these strains and conditions ([Figure 1, A and B](#F1){ref-type="fig"}, and Supplemental Figure S1, A and B). The requirement of Elm1 and Gin4 for Bnr1-GFP localization was even more obvious when we measured the background-corrected fluorescence intensity of Bnr1-GFP at the bud neck relative to Myo1-CFP at the bud neck in *gin4∆* and *elm1∆* strains ([Figure 1C](#F1){ref-type="fig"}). In wild-type cells, the Bnr1-GFP--to--Myo1-CFP fluorescence intensity ratio had a mean ratio of 0.501 ± 0.041 (mean ± SE; *n* = 83). The *gin4∆* and *elm1∆* strains exhibited a significantly decreased mean of the fluorescence intensity ratio compared with the wild-type strain (*p* \< 0.0001). The *gin4∆* strains showed a mean of 0.036 ± 0.028 (*n* = 104); *elm1Δ* strains showed a mean of 0.007 ± 0.029 (*n* = 100); the differences in the mean fluorescence intensity ratios of the *gin4∆* and *elm1∆* strains were not statistically significant (*p* = 0.4787). The negative values observed in the *gin4∆* and *elm1∆* strains are due to loss of Bnr1 at the neck, with the concomitant increase in the fluorescence intensity of Bnr1 in the cytoplasm (where we measured the background fluorescence intensity). The mean, background-corrected fluorescence intensity for Myo1 was 117.9, 100, and 108 arbitrary units (AU) for wild type, *gin4*Δ, and *elm1*Δ, respectively. The mean, background-corrected fluorescence intensity for Bnr1 was 48.8, 1.1, and 2.5 AU for wild type, *gin4*Δ, and *elm1*Δ, respectively. Therefore these experiments demonstrate that Bnr1 localization is dependent, in part, on the septin-associated kinases Gin4 and Elm1.

![Partial requirement for Gin4 and Elm1 for the localization of full-length Bnr1. (A) The absence of Gin4 or Elm1 disrupts the localization of Bnr1-GFP to the bud neck, unlike the absence of Nap1 and Shs1. Shown is the mean percentage of Myo1-CFP--positive cells with Bnr1-GFP localization at the bud neck for the number of cells counted (indicated in parentheses). Experiments were performed twice with \>100 cells per sample. (B) Representative images of Bnr1-GFP and Myo1-CFP in the indicated strains. Cells were fixed after 4 h at 37°C and imaged in three dimensions with five 0.5-μm stacks using the same exposure conditions for all strains. Scale bar, 5 μm. Shown are representative, normalized, maximum-projection images. (C) The ratio of the fluorescence intensity of Bnr1 (YFP) to Myo1 (CFP) was measured (see *Materials and Methods* for details) in the cells imaged in B. Each point represents the ratio of the background-corrected fluorescence intensity of Bnr1 to Myo1 for one cell; bars, mean ± SE.](4041fig1){#F1}

A *gin4Δ elm1Δ* double-deletion strain showed no further decrease in the percentage of cells with Bnr1 localization than either single deletion (Supplemental Figure S1C). This is consistent with published genetic data suggesting that Elm1 and Gin4 collaborate to promote septin function ([@B26]). The Nap1 protein is believed to be an upstream activator of Gin4 ([@B1]); *nap1Δ* shows aberrant septin staining similar to a *gin4Δ* strain ([@B26]). However, in a *nap1Δ* strain, we observed only a small decrease in Bnr1 localization to the bud neck at either temperature tested ([Figure 1A](#F1){ref-type="fig"} and Supplemental Figure S1, A and B). This suggests that the partial requirement of Gin4 and Elm1 for the localization of Bnr1 is not likely to be solely due to abnormal septins. Moreover, deletion of the nonessential septin Shs1 did not affect Bnr1 localization at any temperature tested, although it is required for normal Myo1 localization ([Figure 1A](#F1){ref-type="fig"} and Supplemental Figure S1, A and B). The steady-state levels of Bnr1-GFP protein were modestly reduced in *gin4Δ* or *elm1Δ* strains by comparison with wild-type, *nap1Δ*, or *shs1Δ* strains (Supplemental Figure S1B). However, the experiments described later using Bnr1-truncation constructs whose levels are not affected by these gene deletions demonstrate that Gin4 and Elm1 have a specific role in targeting Bnr1 to the bud neck. Taken together, our data suggest that Bnr1 localization to the bud neck specifically involves Elm1 and Gin4.

The Bnr1 L2 domain is required for Gin4-dependent localization
--------------------------------------------------------------

Previously published work defined two separate localization signals within the Bnr1 N-terminus ([@B23]). Amino acids 1--466, or "L1," is required for the normal concentration of Bnr1 on the mother side of the bud neck. Amino acids 466--733, or "L2," is required for the proper timing of bud neck recruitment (at the onset of bud emergence) and dissociation (at the start of cytokinesis/septin splitting; [@B23]). We independently confirmed and extended these findings to define the domain that mediates Gin4-dependent Bnr1 recruitment.

We generated a series of Bnr1 truncations expressed from the *BNR1* promoter ([Figure 2A](#F2){ref-type="fig"}). Bnr1 constructs with the first 660 or 758 amino acids localized with a similar pattern and apparent fluorescence intensity as full-length Bnr1-GFP ([Figure 2B](#F2){ref-type="fig"}). A construct with only the first 596 amino acids of Bnr1 localized to the bud neck but with a less robust signal than full-length Bnr1-GFP ([Figure 2B](#F2){ref-type="fig"}). Although there was variation in the steady-state protein expression of these truncation constructs, there was no correlation between the expression level and the robustness of the signal of Bnr1 at the bud neck (Supplemental Figure S2A).

![The Gin4 effect on Bnr1 localization is mediated by the L2 domain of Bnr1. (A) Domain architecture of Bnr1. DAD, Diaphanous autoregulatory domain; DD, dimerization domain; DID, Diaphanous inhibitory domain; FH1, formin homology 1; FH2, formin homology 2; GBD, GTPase-binding domain; IH, interdomain helix. The truncations used in the experiments in C are indicated. (B) Endogenous-level expression of Bnr1-758--GFP or Bnr1-660--GFP defines a minimal localization signal for Bnr1. Images are maximum-intensity projections with normalized fluorescence intensity. (C) C-terminally GFP-tagged Bnr1 constructs containing either L1 or L2 were expressed from the inducible *GAL1,10* promoter. Bnr1 L2 (596--758) requires Gin4 for localization to the bud neck. Cells were fixed after 1 h (L2) or 4 h (L1 and ΔL1) of induction with medium containing 2% galactose. (D) Endogenous-level Bnr1 constructs confirm a requirement for Bnr1-L2 for Gin4-dependent localization to the bud neck. Note that images were chosen to represent the fluorescence intensity of the Bnr1 constructs rather than the percentage of Bnr1 localized to the bud neck. (C, D) Number in the upper left indicates the average percentage of cells with Bnr1 localized to the bud neck (*n* \> 100 cells; three independent experiments). (B--D) Cells were imaged in three dimensions with five 0.5-μm stacks using the same exposure conditions for all experiments. Images are normalized, maximum-projection images; scale bar, 5 μm. (E) Fluorescence intensity of full-length 3GFP-Bnr1, 3GFP-Bnr1-ΔL1, or 3GFP-Bnr1-ΔL2 measured from the images obtained for *bnr1Δ* strains as in D. Each point represents the background-subtracted fluorescence intensity of a single cell (in arbitrary units); bars, mean ± SE.](4041fig2){#F2}

The localization of the Bnr1 minimal localization domain (Bnr1-660--GFP) was strikingly compromised in the absence of Gin4. In *gin4Δ* strains at room temperature, only 47% of cells showed Bnr1-660--GFP localization at the bud neck. In those cells that did show bud neck signal of Bnr1-660--GFP, the fluorescence intensity appeared to be markedly reduced (Supplemental Figure S2B). These findings are not due to differences in protein expression because the steady-state expression of Bnr1-660--GFP was comparable in the wild-type and *gin4Δ* strains (Supplemental Figure S2C). Thus we have determined the minimal domain of Bnr1 sufficient for localization at endogenous levels and confirmed that Gin4 is partially required for its recruitment to the bud neck. Similar results were obtained in *elm1Δ* strains (unpublished data).

We next examined the role of the L1 and L2 domains in the Gin4-dependent localization of Bnr1. When overexpressed from the *GAL* promoter, the L1 and L2 constructs gave the expected patterns of localization. L1 concentrated at the mother side of the bud neck but failed to dissociate from the bud neck after the septin rings split during mitotic exit; L2 failed to display the mother-side bias but exhibited a cell cycle--regulated localization that mirrored the full-length protein ([Figure 2C](#F2){ref-type="fig"}). Of great interest, L2 localization was entirely dependent upon the presence of Gin4, whereas L1 localized independently of Gin4. Moreover, an N-terminal deletion lacking L1 (Bnr1-ΔL1(596-C)--GFP) also exhibited an absolute requirement for Gin4 for its localization ([Figure 2C](#F2){ref-type="fig"}). The expression of these constructs was similar in all of the strains examined (Supplemental Figure S2D).

The specific requirement of the L2 domain for Gin4-dependent localization was confirmed using domain deletion constructs expressed from the native promoter. For these experiments full-length Bnr1 and ΔL1 (466--C) and ΔL2 (466--733) derivatives were visualized with an N-terminal triple GFP tag ([Figure 2D](#F2){ref-type="fig"}). Using maximum-projection images, which were obtained with the same imaging conditions for all the strains, we compared the fluorescence intensity at the bud neck of the different truncation constructs in the *bnr1Δ* strains ([Figure 2E](#F2){ref-type="fig"}). After subtracting the background fluorescence in the cytoplasm, we observed that 3GFP-Bnr1 full-length (mean ± SE, 974.5 ± 53.7 AU) and 3GFP-Bnr1-ΔL1 displayed similar mean fluorescence intensities (795.8 ± 42.5 AU). In contrast, 3GFP-Bnr1-ΔL2 showed a clear decrease in the signal at the bud neck (297.4 ± 14.9 AU). These results suggest that the Gin4/Bnr1 L2 mechanism for Bnr1 localization is more important than the L1 domain--dependent mechanism. In contrast with 3GFP-Bnr1-ΔL2 or the full-length control, 3GFP-Bnr1ΔL1 localization was entirely dependent upon Gin4 ([Figure 2D](#F2){ref-type="fig"}). The steady-state protein expression of these constructs was comparable in wild-type cells. Although there was decreased expression of all three Bnr1 constructs in the *gin4Δ* strains, the expression difference was more pronounced for full-length 3GFP-Bnr1 than for 3GFP-Bnr1-ΔL1 or 3GFP-Bnr1-ΔL2 (Supplemental Figure S2E). Therefore the analysis of these constructs is consistent with the data from the overexpression experiments: the L2 domain of Bnr1 specifically requires Gin4 for its ability to localize to the bud neck.

Gin4, Elm1, and Shs1 are required for the ability of Bnr1 to assemble actin cables
----------------------------------------------------------------------------------

Although neither *BNR1* nor *BNI1* is essential for the viability of yeast cells, cells lacking both formins are inviable because of the inability to undergo polarized morphogenesis ([@B31]; [@B35]; [@B17]; [@B60]). Thus synthetic lethality with deletions of *BNI1* or mutations that conditionally inactivate Bni1 protein identifies candidate genes that might collaborate with *BNR1*. Large-scale synthetic genetic array data identified *elm1*Δ, *gin4Δ, nap1*Δ, and *shs1*Δ as having synthetic growth defects with *bni1*Δ ([@B66], [@B67]; [@B14]). By directed genetic crosses, we confirmed these findings and found that a *gin4Δ bni1Δ* double deletion is nearly lethal, similar to the growth phenotype of *bni1Δ bnr1Δ* (Supplemental Figure S3A). The double-deletion strains *shs1Δ bni1Δ* and *elm1Δ bni1Δ* had temperature-sensitive synthetic growth defects at 30 and 35°C (Supplemental Figure S3A). In contrast, relative to the single-mutant strains, *nap1Δ bni1Δ* double-mutant strains did not display a synthetic growth defect (Supplemental Figure S3A). Because the aforementioned double-deletion strains rapidly developed suppressor mutations, *elm1*Δ, *gin4Δ, nap1*Δ, and *shs1*Δ were combined with the *bni1-1* temperature-sensitive allele. The *bni1-1* allele contains a mutation in the coding sequence for the FH2 domain; *bnr1Δ bni1-1* strains are inviable at 34°C and lose all actin cables within a 4-min shift to the nonpermissive temperature ([@B60]). The *gin4Δ bni1-1* and *elm1Δ bni1-1* strains were, to differing degrees, temperature sensitive for growth: *gin4Δ bni1-1* failed to grow at 35°C, whereas *elm1Δ bni1-1* had a slow-growth phenotype at 35°C and failed to grow at 37°C ([Figure 3A](#F3){ref-type="fig"} and Supplemental Figure S3B). By contrast, *nap1Δ bni1-1* strains grew normally at all temperatures ([Figure 3A](#F3){ref-type="fig"}). These data may be explained by the requirement for these genes to localize Bnr1 because of the close correlation of the growth phenotype with the requirement for Bnr1 bud neck localization. Of interest, the *shs1Δ bni1-1* strains also had a growth defect at 35°C and were inviable at 37°C ([Figure 3A](#F3){ref-type="fig"}), despite the fact that Bnr1 localizes normally at all temperatures in strains lacking Shs1. This raises the possibility that Gin4 and Elm1 are required for both Bnr1 function and localization, whereas Shs1 may be specifically required for Bnr1 function.

![Bnr1-mediated actin cable assembly requires Gin4, Elm1, and Shs1. (A) Temperature-sensitive growth of gin4*Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* strains. Fivefold dilutions of cells were spotted on yeast extract/peptone/dextrose plates and grown for 1 d at 35°C (middle) or 37°C (bottom) or for 2 d at 24°C (top). (B) Myo2-GFP localization is depolarized in *gin4Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* after a 15-min shift to 35°C. Cells were imaged in three dimensions with five 0.5-μm stacks using the same exposure conditions for all experiments. Images are maximum-projection images; scale bar, 5 μm. (C) Quantification of Myo2-GFP localization from experiments in B. Cells of the indicated genotype were scored for Myo2-GFP localization to the bud tip (white with dots) or the bud neck (black) or unpolarized localization (gray). Experiments were performed three times (*n* \> 200 cells for each repetition). For each double mutant, at least two independent clones from different spores were analyzed (data not shown).](4041fig3){#F3}

The morphogenesis checkpoint delays the cell cycle of budding yeast when bud formation is impaired. The Swe1 kinase is the central mediator of this checkpoint ([@B40]). Septin perturbations lead to Swe1-dependent cell cycle delays. Deletion of Swe1 in strains lacking septins or septin-associated components can suppress the elongated morphology and growth defects that are characteristic of these strains. However, *swe1Δ* does not rescue the septin defects in these strains ([@B4]; [@B63]; [@B46]). Genetic crosses were performed to determine whether the synthetic growth defect of *gin4Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* strains could be explained by the activation of Swe1. However, the additional deletion of *SWE1* did not rescue the temperature sensitivity of these double mutant strains (Supplemental Figure S3C) and, in fact, resulted in a more pronounced growth defect. This additional growth defect may be explained by the previously described growth defect of *swe1∆ bni1∆* strains ([@B67]). Therefore the synthetic growth defects of *gin4Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* strains are not due to activation of the morphogenesis checkpoint.

Next we determined whether Gin4, Elm1, and Shs1 promote Bnr1-dependent actin cable assembly by labeling *gin4Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* strains with Alexa 568--phalloidin. In common with *bnr1Δ bni1-1* strains ([@B60]), *gin4Δ bni1-1* and *elm1Δ bni1-1* strains lost most actin cables after a 15-min shift to 35°C. Of interest, *shs1Δ bni1-1* cells also displayed a loss of actin cables after the temperature shift (Supplemental Figure S3C). In parallel, we used an endogenous-level GFP-tagged copy of the type V myosin, Myo2, to evaluate the presence of intact actin cables. Most polarized transport in budding yeast is carried by Myo2 along actin cables ([@B54]; [@B57]). As expected, after a 15-min shift to 35°C of a *bnr1Δ bni1-1* strain, the bud tip polarization of Myo2 was lost. Myo2 polarization was similarly disrupted in *gin4Δ bni1-1*, *elm1Δ bni1-1*, and *shs1Δ bni1-1* strains at the restrictive temperature ([Figure 3, B and C](#F3){ref-type="fig"}). Thus Elm1, Gin4, and Shs1 are all required for normal actin cable assembly by Bnr1.

Gin4 kinase activity is not required for actin cable assembly by Bnr1 in vivo
-----------------------------------------------------------------------------

We next examined whether the kinase activity of Gin4 or its role in septin organization promotes Bnr1 function. The possibility that Gin4 kinase activity could be required was suggested by the fact that Elm1 is an upstream kinase for Gin4 that promotes its kinase activity ([@B63]; [@B3]). However, the kinase activity of Gin4 is not absolutely required for the role of Gin4 in regulating septin architecture ([@B44]; [@B50]). Constructs encoding full-length Gin4 or a Gin4 deletion lacking the kinase domain (amino acids 17--280; [@B32]) were introduced into a *gin4Δ bni1-1* strain. Full-length Gin4-2HA and Gin4Δkinase-2HA expression complemented the growth defect of *gin4Δ bni1-1* strains comparably at the restrictive temperature (35°C; [Figure 4B](#F4){ref-type="fig"}). Moreover, Gin4Δkinase-2HA expression also corrected the defect in the bud neck localization of Bnr1 (Supplemental Figure S4A), as well as the defect in polarized Myo2 localization ([Figure 4, C and D](#F4){ref-type="fig"}). The epitope-tagged, full-length Gin4 does not complement as well as the untagged control, but the tagged Gin4Δkinase complements as well as the tagged full-length Gin4. Note that the tagged proteins are expressed at lower steady-state levels than the untagged control and that the Gin4Δkinase-2HA protein is expressed at lower levels than the full-length Gin4-2HA ([Figure 4C](#F4){ref-type="fig"}). However, despite its lower expression, Gin4Δkinase-2HA complements in the functional assays comparably to the better-expressed full-length Gin4-2HA. Thus the regulation of Bnr1 by Gin4 does not require the Gin4 kinase activity.

![The role of Gin4 in localization and activation of Bnr1 is independent of its kinase domain. (A) Domain architecture of Gin4. The kinase domain of Gin4 (18--280) and phospholipid-binding domain are indicated. (B) The temperature-sensitive growth defect of *gin4Δ bni1-1* strains is rescued by both \[*pGIN4-GIN4-2HA*\] and \[*pGIN4-Δkinase-2HA*\] but not by the control vector. Fivefold dilutions of cells were spotted on --Ura plates and grown for 1 d at 35°C (right) or 2 d at 24°C (left). (C) Comparative Western blotting with anti-Gin4 in *gin4Δ bni1-1 MYO2-GFP* strains shows that the level of Gin4 correlates with the rescue of polarized assembly observed in D and E. (D) Myo2-GFP localization is polarized when the *gin4Δ bni1-1* strain is rescued by either \[*pGIN4-GIN4-2HA*\] or \[*pGIN4-Δkinase-2HA*\]. We also compared complementation with an untagged \[*pGIN4-GIN4*\], which showed similar Myo2-GFP localization to the tagged Gin4 plasmids. Images were collected and analyzed as in [Figure 3B](#F3){ref-type="fig"}. Scale bar, 5 μm. (E) Quantification of Myo2-GFP localization from experiments in D. Cells of the indicated genotype were scored for Myo2-GFP localization to the bud tip (white with dots) or the bud neck (black) or unpolarized localization (gray). Experiments were performed three times (*n* \> 200 cells for each repetition).](4041fig4){#F4}

Gin4 binds directly to the Bnr1-758 minimal localization domain
---------------------------------------------------------------

Next we examined whether Elm1 and Gin4 interact with Bnr1 in vivo. We generated a *BNR1-758-13myc* strain with either Elm-TAP-- or Gin4-TAP--tagged protein. The TAP tag consists of a calmodulin-binding peptide, a TEV cleavage site, and two immunoglobulin G--binding domains of *Staphylococcus aureus* protein A. We performed immunoprecipitations with an anti--calmodulin binding protein (CBP) antibody and probed Western blots with an anti-CBP antibody (to detect Elm1 or Gin4) and an anti-myc antibody (to detect Bnr1). Bnr1-758 bound Gin4-TAP in buffer containing 150 mM KCl ([Figure 5A](#F5){ref-type="fig"}). This binding is specific because Elm1 does not bind to Bnr1-758 in these conditions.

![Bnr1-N interacts with Gin4-C in vivo and in vitro. (A) Immunoprecipitations from yeast extracts using an anti-CBP antibody in *BNR1-758-13myc* strains that also expressed either Elm1-TAP or Gin4-TAP. In 150 mM KCl, Bnr1-758 bound to Gin4 but not Elm1. (B) Bnr1-758 interacts with Gin4 in a kinase domain--independent manner. Immunoprecipitations from yeast extracts using an anti-HA antibody in *gin4Δ BNR1-758-13myc* strains that were complemented with *CEN URA* plasmids bearing no insert (control), \[*pGIN4-GIN4-2HA*\], or \[*pGIN4-Δkinase-2HA*\]. At 75 mM KCl, we detected binding of Bnr1-758-13myc to Gin4Δkinase-2HA (Gin4Δk) but little if any binding to full-length Gin4-2HA. At 150 mM KCl, we detected robust binding of Bnr1-758-13myc to Gin4-2HA but less to Gin4∆k-2HA. The immunoprecipitations in A and B were performed at least three times; representative Western blots are shown. (C, D) Full-length Bnr1 and Bnr1-N bind directly to Gin4 in a kinase-independent manner. Bnr1 was present at 56 nM, and all Gin4 constructs were present at 120 nM. (C) We used glutathione agarose to pull-down full-length GST-Gin4 or GST-Gin4Δkinase in the presence of 6His-Bnr1 and probed Western blots with anti-His antibodies. Bnr1\* denotes the N-terminal proteolysis product that occurs during the purification of full-length Bnr1. Both Bnr1 full-length and Bnr1\* bound more robustly to GST-Gin4 full length at 150 mM KCl than at 75 mM KCl, whereas they bound more robustly to GST-Gin4Δkinase at 75 mM KCl. (D) Pull-down of 6His-Bnr1 full-length and 6His-Bnr1-758 (Bnr1-N) with pCAL-n-FLAG-Gin4-C (amino acids 540--1142); controls (--) were performed without Gin4-C added. At 75 mM KCl, we found that Bnr1 full-length, Bnr1\*, and Bnr1-N bound to Gin4-C; Bnr1-N and Bnr1\* bound more robustly than full-length Bnr1. Note that we consistently observed an additional band in the anti-His Western blots of the pull-downs (marked with an asterisk) when both Bnr1 and Gin4-C were combined; this band was not present in the inputs of any of the individual proteins. Note that in D the inputs are diluted to 56 nM and 120 nM, whereas in C the Bnr1 input is present at 120 nM. The pull-downs were resuspended in minimal volumes of sample buffer before resolving by SDS--PAGE, which results in the apparent increase in the concentration of protein in the pull-down lanes. All pull-down experiments were performed at least two times; representative Western blots are shown. (E) Coomassie-stained gel of the purified proteins used in the pull-down experiments. Note that these represent three different SDS--PAGE gels for the three different sets of proteins. For Western blots and gels, lanes that were not relevant to the experiments here may have been removed.](4041fig5){#F5}

To further investigate the interaction of Gin4 with Bnr1 in vivo, we generated a *gin4Δ* strain that expressed Bnr1-758-13myc from the *BNR1* locus and introduced centromeric plasmids to express Gin4-2HA and Gin4Δkinase-2HA from the *GIN4* promoter. We performed immunoprecipitations with an anti-hemagglutinin (HA) antibody and probed Western blots with anti-HA antibody (Gin4) and anti-myc antibody (Bnr1). At 75 mM KCl, we detected binding of Bnr1-758-13myc to Gin4Δkinase-2HA but not to full-length Gin4-2HA ([Figure 5B](#F5){ref-type="fig"}). At 150 mM KCl, we also detected binding of Bnr1-758-13myc to Gin4-2HA ([Figure 5B](#F5){ref-type="fig"}).

Pull-down experiments with purified proteins were performed to determine whether the interaction between Bnr1 and Gin4 was direct. Hexahistidine (6His)-Bnr1 was purified from yeast; glutathione *S*-transferase (GST)--Gin4 and GST-Gin4Δkinase were purified from *Escherichia coli* ([Figure 5E](#F5){ref-type="fig"}). We used glutathione agarose to pull-down GST-Gin4 full length or GST-Gin4Δkinase in the presence of 6His-Bnr1 and probed Western blots with anti-His antibodies. Bnr1 was at 56 nM; all GST proteins were at 120 nM. Note that the purification of full-length Bnr1 yields a proteolysis product (Bnr1\*), which is an N-terminal fragment similar in size to the Bnr1-758 used in the immunoprecipitation experiments. Both Bnr1 full length and Bnr1\* bound more robustly to full-length Gin4 at 150 mM KCl than at 75 mM KCl. In contrast, they bound more robustly to Gin4Δkinase at 75 mM KCl ([Figure 5C](#F5){ref-type="fig"}). The basis for these salt-dependent effects is not clear, but the following points may be relevant. First, the results are highly reproducible, and we note that the salt-dependent effects are seen with the immunoprecipitations from extracts ([Figure 5B](#F5){ref-type="fig"}) as well as with purified proteins. Second, some effects may be explained by the known regulatory autoinhibition of Gin4, which may be in a more open conformation at higher salt concentration ([@B4]; [@B50]). If this were the case, we would predict that the Gin4 construct lacking the kinase domain would be able to interact at the lower salt concentration; indeed, our experiments are consistent with this prediction ([Figure 5, B and C](#F5){ref-type="fig"}). What remains unclear is why the interaction of Gin4Δkinase with Bnr1-758 is inhibited by higher salt concentration. This mutant may not properly fold in this condition or might bind another protein in the extract. Nevertheless, our data demonstrate that the N-terminal minimal localization domain of Bnr1 binds to Gin4 in a kinase-independent manner. Moreover, our experiments suggest that the interaction is direct.

To independently confirm these results, we performed a pull-down of full-length 6His-Bnr1 and 6His-Bnr1-758 (Bnr1-N) with a different Gin4 construct (Gin4-C), which contained amino acids 540--1142. At 75 mM KCl, we found that both Bnr1 full length and Bnr1-N bound to Gin4-C; Bnr1-N and Bnr1\* bound more robustly than full-length Bnr1 ([Figure 5D](#F5){ref-type="fig"}). We speculate that this is due to autoinhibition of full-length Bnr1. Taken together, our data suggest that the N-terminal minimal localization domain of Bnr1 binds directly to the C-terminal of Gin4.

A defect in the function of Bnr1 explains the growth defect of the *gin4Δ bni1-1* and *shs1Δ bni1-1* strains
------------------------------------------------------------------------------------------------------------

Our genetic data raised the possibility that Shs1 and Gin4 are required for the activation of Bnr1. To test this hypothesis directly, we determined whether constitutively active Bnr1 would suppress the temperature-sensitive growth of strains lacking either Gin4 or Shs1 in combination with Bni1. Prior work suggests that, like other DRFs, Bnr1 is negatively regulated by autoinhibition due to the interaction of the N-terminal RBD/DID with the C-terminal DAD domain. For DRFs, including Bnr1, disruption of either the DID or the DAD domain results in the constitutive activation of actin filament assembly ([@B16]; [@B12]). Bnr1∆L1 lacks amino acids 1--466, which include the RBD and DID domains. In common with other constitutively active formins in budding yeast, overexpression of Bnr1∆L1 is lethal ([@B21]; our unpublished data). Strikingly, expression of 3GFP-Bnr1ΔL1, but not 3GFP-Bnr1, strongly suppressed the growth defect of the *gin4Δ bni1-1 bnr1Δ* or the *shs1Δ bnr1Δ bni1-1* strain ([Figure 6A](#F6){ref-type="fig"}). However, expression of 3GFP-Bnr1ΔL2 did not suppress the growth defect of the *gin4Δ bni1-1 bnr1Δ* strains (Supplemental Figure S5). Note that for this experiment all constructs are slightly (twofold to threefold) overexpressed because they are carried on centromeric plasmids. Presumably, this is why there was a small degree of complementation by the full-length 3GFP-Bnr1 in the *gin4Δ bni1-1 bnr1Δ* strain and may explain why the *shs1Δ bni1-1 bnr1Δ* strains show a growth defect at the permissive temperature. However, Western blotting demonstrated that the phenotypes of these strains could not be explained by the expression levels of the constructs (Supplemental Figure S2E). Most significantly, Bnr1∆L1 and Bnr1∆L2 are expressed comparably in all strains, but only Bnr1∆L1 suppresses the growth defect. Finally, Alexa 568--phalloidin labeling demonstrated that the Bnr1∆L1 but not the full-length protein restored actin cable assembly in the *gin4Δ bni1-1 bnr1Δ* or *shs1Δ bnr1Δ bni1-1* strain ([Figure 6B](#F6){ref-type="fig"}).

![Expression of activated Bnr1 rescues *gin4Δ bnr1Δ bni1-1* and *shs1Δ bnr1Δ bni1-1* growth defect and actin polarity defect. (A) Expression of \[*pBNR1-3GFP-BNR1ΔL1*\] rescues the temperature-sensitive phenotype of *gin4Δ bnr1Δ bni1-1* and *shs1Δ bnr1Δ bni1-1* strains, but \[*pBNR1-3GFP-BNR1*\] expression has little effect. Tenfold dilutions of cells were spotted on −Ura plates and grown for 2 d at 33°C (bottom) or 3 d at 24°C (top). (B) Phalloidin actin staining in cells fixed after 5 min at 33°C. Images are deconvolved and maximum-projection images generated from 0.3-μm stacks. The percentage of cells with actin cable staining is given in the lower left corner; cells were scored as positive for actin cables when any linear actin structures were detected. Arrowheads indicate cells with actin cables. Experiments were performed two times (*n* \> 100 cells for each experiment). For each strain, we analyzed two independent isolates, which both showed similar effects on growth and actin cable staining. Scale bar, 5 μm.](4041fig6){#F6}

3GFP-Bnr1ΔL1 is not localized to the bud neck in a *gin4Δ* strain ([Figure 2, C and D](#F2){ref-type="fig"}); however, 3GFP-Bnr1ΔL1 localization in a *shs1Δ* strain is normal (unpublished data). Therefore, to confirm the rescue of the *gin4Δ bni1-1* with the activated Bnr1, we generated a Bnr1 deletion lacking the DAD domain. Bnr1∆DAD-GFP displays partial localization in a *gin4Δ* strain (unpublished data). Cells that express Bnr1ΔDAD-3HA contain disorganized arrays of short cables and display impaired movement of GFP-Sec4 particles ([@B12]). We generated a strain expressing Bnr1ΔDAD-3HA at the endogenous level as in [@B12]. The strain *bnr1ΔDAD-3HA gin4Δ bni1-1* exhibited improved growth at 35°C relative to the *gin4Δ bni1-1* control strain ([Figure 7A](#F7){ref-type="fig"} and Supplemental Figure S6A). Thus truncating the DAD domain of Bnr1 partially rescued the defect in Myo2 polarization of the *gin4Δ bni1-1* strain at the restrictive temperature ([Figure 7, B and C](#F7){ref-type="fig"}). Finally, Alexa 568--phalloidin labeling demonstrated that the Bnr1∆DAD truncation restored actin cable assembly in the *gin4Δ bni1-1* strain (Supplemental Figure S6B). Taken together, our data suggest a novel role for Gin4 and Shs1 in the activation of Bnr1.

![Expression of activated Bnr1 rescues *gin4Δ bni1-1* growth defect and actin polarity defect. (A) Expression of *bnr1ΔDAD-3HA* partially rescues the temperature-sensitive phenotype of a *gin4Δ bni1-1* strain. Fivefold dilutions of cells were spotted on yeast extract/peptone/dextrose plates and grown for 1 d at 35°C (bottom) or 2 d at 24°C (top). (B) Myo2-GFP localization is unpolarized in *gin4Δ bni1-1* but shows an increased polarization in *gin4Δ bni1-1 bnr1ΔDAD-3HA*. Images were acquired and analyzed as in [Figure 3B](#F3){ref-type="fig"}. Scale bar, 5 μm. (C) Quantification of Myo2-GFP localization from experiments in B. Cells of the indicated genotype were scored for Myo2-GFP localization to the bud tip (white with dots) or the bud neck (black) or unpolarized localization (gray). Experiments were performed two times (*n* \> 100 cells for each repetition). For *gin4Δ bni1-1 bnr1ΔDAD-3HA* strains, we analyzed two independent isolates, which both showed similar effects on growth and Myo2-GFP localization.](4041fig7){#F7}

DISCUSSION
==========

In this study, we demonstrated that the MARK/Par1-family, septin-associated kinase Gin4 has an important role in localizing and activating Bnr1 at the bud neck. In addition, our experiments reveal an unexpected requirement for the septin Shs1 in the activation of Bnr1.

Control of Bnr1 localization by septins and Gin4
------------------------------------------------

Bnr1 has two independent localization signals; each one controls a distinct element of the localization of Bnr1. L1 specifies the spatial (mother-side bias) localization; L2 is required for the accurate temporal localization of Bnr1 through the cell cycle ([@B23]). Both L1 and L2 require an intact septin cytoskeleton for localization to the bud neck ([@B23]). However, two-hybrid experiments failed to detect an interaction of the Bnr1 N-terminus, L1, or L2 with individual septin subunits ([@B37]; [@B23]). Here we show that Bnr1 L2 requires Gin4 for its localization to the bud neck. Gin4 localization to the bud neck is septin dependent ([@B44]), which is consistent with the observation that localization of Bnr1 L2 requires an intact septin cytoskeleton for its localization ([@B23]). The activity and localization of Gin4 are highly regulated through the cell cycle ([@B1]; [@B44]; [@B50]; [@B3]). Like Bnr1, Gin4 localizes to the bud neck at the onset of bud emergence and leaves the bud neck at the start of cytokinesis ([@B44]; our unpublished data). Gin4 is not localized in cells treated with α-factor ([@B44]); similarly, Bnr1 is not localized and is not required for the assembly of actin cables in mating projections ([@B8]; our unpublished data). Therefore Gin4 is an excellent candidate to mediate the cell cycle--specific and developmental regulation of Bnr1 localization.

L2 is located in a previously uncharacterized region of Bnr1. We performed homology scanning of Bnr1 sequences from sensu lato yeast and fungi, as well as with the formins Bni1 from budding yeast and cdc12 from fission yeast (see *Materials and Methods* for details). This method examines the alignments of protein sequences and scores the relative similarity along the length of the protein sequences ([@B15]). We chose to compare sensu lato yeast and fungal Bnr1 sequences, as they all have Gin4 homologues. In contrast, there is no evidence that either Bni1 or Cdc12 requires the septin cytoskeleton for localization. Supplemental Figure S7 shows the sequence similarity of Bnr1 1--758 from sensu lato yeast (blue), fungi (pink), and Bni1 and Cdc12 (yellow). Of interest, in sensu lato yeast, there is a well-conserved peak at 639−660 (marked with two asterisks), which is not present in Bni1 or Cdc12 but is slightly similar in fungal Bnr1 sequences. We speculate that this region may be important for binding of Bnr1 to Gin4. Indeed, our structure--function analysis ([Figure 2](#F2){ref-type="fig"}) is consistent with this hypothesis.

The binding partner of Bnr1 L1 remains to be identified. Deletion of Rho4, a known binding partner of Bnr1 ([@B37]), did not affect the localization of full-length Bnr1, Bnr1 L1, or Bnr1 L2 (unpublished data). Our homology scanning data showed that L1 (amino acids 35--501) contains one peak that is well conserved among sensu lato Bnr1 sequences and fungal Bnr1 sequences but is not present in Bni1 or Cdc12 (Supplemental Figure S7, marked with an asterisk). This sequence (amino acids 100--135) contains a high number of basic residues and has a pI of 9.5. The presence of a basic-rich region (BRR) is consistent with published reports that demonstrate that a BRR on the N-terminus of mDia1 and mDia2 binds to phospholipids ([@B58]; [@B28]). Alternatively, the peak in L1 may be a novel septin-binding domain.

Regulation of Bnr1 by Gin4 and Shs1
-----------------------------------

Our data demonstrate that Gin4 is at least required for localization of Bnr1 to the bud neck. Moreover, a *gin4Δ bni1-1* strain showed temperature-sensitive growth caused by a loss of polarized actin cables. Of interest, Shs1 did not affect the localization of Bnr1 to the bud neck at any temperature tested, but a *shs1Δ bni1-1* strain showed a temperature-sensitive growth defect and a loss of polarized actin cables. Bnr1 can be activated by truncation of the N-terminal RBD or the C-terminal DAD ([@B21], [@B22]; [@B12]). Deletion of the RBD/DID domains of Bnr1 can suppress the temperature-sensitive growth and the polarized actin defect of both the *gin4Δ bni1-1* and *shs1Δ bni1-1* strains. Moreover, activation of Bnr1 by truncation of the DAD domain can partially rescue the growth and actin assembly defects of the *gin4Δ bni1-1* strain. There are several possible explanations for the partial rescue with the truncation of the DAD domain. The cables generated by Bnr1ΔDAD are short but numerous and have defects in Sec4 particle movement ([@B12]). In addition, the DAD domain can bind to G-actin and has a role in the nucleation of actin filaments ([@B29]). Finally, our localization data suggest that *bnr1ΔDAD-3HA gin4Δ bni1-1* strains would only have partial localization of Bnr1 to the bud neck (∼67% at room temperature). Thus it is possible that only some cells would have cables present at the bud neck, and those cables would be less organized than full-length Bnr1.

One unresolved issue from our work is why Elm1 shows synthetic lethality and actin polarization defects in combination with *bni1-1*. One might expect that the requirement for Elm1 is due to its ability to phosphorylate and activate Gin4 ([@B63]). However, the kinase domain of Gin4 is not required for the localization or activity of Bnr1. Thus there may be an additional role for Elm1 in the regulation of Bnr1 that is independent of its established activity as a regulator of Gin4.

In general, the relationship between the localization and activation of formins is poorly understood. In budding yeast, nonlocalized formins can support growth, albeit with compromised organization of actin cables and defects in polarized growth ([@B60]; [@B22]). Increasing evidence suggests that localization is a prerequisite for the release of autoinhibition. For mDia1, binding to active Rho regulates the activation and localization to the site of actin assembly ([@B62]). The fission yeast formin for3 must be localized for the release of autoinhibition to occur ([@B48]). Furthermore, reports suggest that the N-terminal BRR of mDia1 and mDia2 is involved in recruiting mDia to the plasma membrane, permitting activation by the binding of Rho-GTPase to the DID/RBD ([@B58]; [@B28]). These data suggest that activation of formins may be controlled by a coincidence detection mechanism by which multiple inputs contribute to the complete activation of the formin; such a mechanism would ensure that actin nucleation occurs only at appropriate sites of actin assembly ([@B28]).

Our results demonstrate that the budding yeast formin Bnr1 is regulated by an autoinhibition mechanism, similar to other DRFs. Our genetic data suggest that the loss of Gin4 can be overcome by activation of Bnr1. Because Gin4 is required for the localization of Bnr1, this result might simply be explained by a requirement for the localization of Bnr1 for the relief of autoinhibition. Gin4 likely interacts with the L2 domain of Bnr1, which is outside the typical domains involved in autoinhibition; therefore Gin4 may be required for the localization of Bnr1 to the bud neck, which then allows the relief of autoinhibition by another factor. The localization of Gin4 closely mirrors that of Bnr1; moreover, Gin4 is highly regulated through the cell cycle. Thus one major function of Gin4 is to control the localization of Bnr1.

Our results also demonstrate that Shs1 is not required for the localization of Bnr1 but is required for its actin assembly activity. Moreover, activated Bnr1 overcomes the requirement for Shs1. We speculate that Shs1, perhaps in combination with other septins, may bind to the L1 domain of Bnr1 and relieve autoinhibition. One simple interpretation of our data would be a stepwise model: Gin4 (in a cell cycle--dependent manner) localizes Bnr1 (via the L2 domain) to the bud neck and then Shs1, together, with Rho-GTPases, contributes to the release of Bnr1 autoinhibition. We also do not exclude the possibility that Gin4 has a direct role in Bnr1 activation in addition to the role we defined in Bnr1 localization. The hypothesis that septins and septin-associated proteins are involved in the regulation of a formin is particularly interesting in light of the established connections between the actin and septin cytoskeletons ([@B52]). Therefore our results may have implications for the regulation of formins in other systems.

MATERIALS AND METHODS
=====================

Strains and plasmids
--------------------

Media and genetic techniques were as previously described ([@B59]). *BNR1-GFP* and *MYO1-CFP* strains were generated as previously described ([@B9]). Deletion strains were obtained from a haploid deletion library (Open Biosystems, Lafayette, CO) and were crossed with strains of interest. Myo2-GFP was obtained from a GFP library (Open Biosystems) and was crossed into the strains of interest. The *bnr1-ΔDAD-3HA* construct was generated as described ([@B12]) and transformed into a wild-type diploid of our strain background (Research Genetics S288C BY4730). GFP-tagged Bnr1 truncations were generated using established methods ([@B45]). See Supplemental Table S1 for complete details about the yeast strains used; additional details are available upon request.

Gin4 plasmids \[*pGIN4-GIN4-2HA*\] and \[*pGIN4-Δkinase-2HA*\] were obtained from the Iwase lab ([@B32]). The Gin4 untagged plasmid was a gift from Mark Longtine ([@B44]). \[*pBNR1-3GFP-Bnr1*\] was previously described ([@B9]). \[*pBNR1-3GFP-Bnr1-ΔL1*\] and \[*pBNR1-3GFP-Bnr1-ΔL2*\] plasmids were obtained from Anthony Bretscher ([@B23]). See Supplemental Table S2 for the complete details on the plasmids used; additional details are available upon request.

Microscopy
----------

All live-cell imaging was performed as previously described ([@B9]). Cells were fixed with 3.7% formaldehyde for 7 min at room temperature, washed three times in phosphate-buffered saline (PBS), and resuspended in a final volume of 50 μl. For galactose-inducible strains, cells were grown overnight in yeast extract/peptone (YEP) with 2% raffinose, refreshed to OD~600~ 0.2 in YEP raffinose, grown to an OD~600~ of 0.4, and induced with 2% galactose in YEP media for 1 h or 4 h, as indicated.

Staining of the actin cytoskeleton using Alexa 568--phalloidin actin was performed as described ([@B60]). For the experiments in Supplemental Figure S3, [Figure 6](#F6){ref-type="fig"}, and Supplemental Figure S6, we imaged cells with at least fifteen 0.3-μm stacks. We scored cells for actin cables by examining every stack in the series; cells were scored as positive for actin cables when any discernible linear actin structures were present.

Analysis of microscopy data
---------------------------

All image manipulations and fluorescence intensity measurements were carried out using SlideBook (Intelligent Imaging Innovations, Denver, CO) software; data were exported to and analyzed in Excel (Microsoft, Redmond, WA) or Prism software (GraphPad Software, La Jolla, CA). For each experiment, images to be compared were obtained using the same exposure time and the same number of *z*-stacks; projection images were generated, and the fluorescence intensities were set to the same minimum and maximum values, thereby normalizing the images for accurate comparison. Fluorescence intensity measurements were made using the mask feature in SlideBook. In cells that were positive for Myo1-CFP signal at the bud neck, we measured the mean fluorescence intensity of both Bnr1 and Myo1 with a mask of 12--18 pixels at the bud neck. We subtracted the background fluorescence, which was calculated by taking the average of the mean fluorescence intensity for three 6-pixel spots in the cytoplasm of each cell. The ratio of yellow fluorescent protein (YFP; Bnr1) to CFP (Myo1) was then determined, and the mean of the samples was calculated. In [Figure 1C](#F1){ref-type="fig"}, each data point represents the ratio of the background-corrected Bnr1-GFP at the bud neck to the background-corrected Myo1-CFP at the bud neck. We judged the statistical significance of the mean of the Bnr1:Myo1 ratio. In the experiments in [Figure 1](#F1){ref-type="fig"}, Bnr1-GFP was visualized with a YFP filter to eliminate the signal from Myo1-CFP. For [Figure 2E](#F2){ref-type="fig"}, we used a similar method to measure the fluorescence intensity of the various Bnr1 constructs at the bud neck and subtracted the background fluorescence intensity, calculated as described.

Western blotting and SDS--PAGE
------------------------------

Standard procedures were used for SDS--PAGE and Western blotting. Mouse anti-myc antibody (9E10; Roche, Basel, Switzerland), rat anti--tubulin α antibody (Accurate Chemical, Westbury, NY), mouse anti-GFP antibody (7.1 and 13.1; Roche, Basel, Switzerland), monoclonal anti-His antibody (GE Healthcare, Little Chalfont, United Kingdom), anti-HA monoclonal (12CA5, Roche), and anti-CBP monoclonal (Millipore, Darmstadt, Germany) were obtained from commercial sources. The anti-Gin4 polyclonal antibody was a gift from Doug Kellogg, University of California, Santa Cruz.

Protein purification
--------------------

### Gin4.

BL21\* cells carrying the *GST-GIN4* plasmid (obtained from Jeremy Thorner, University of California, Berkeley) were grown and purified according to the methods previously described ([@B11]), with the following modifications. Gin4-C (amino acids 540--1142) was expressed with a pCAL-n-FLAG tag (Agilent, Santa Clara, CA) on the N-terminal. Cells carrying this plasmid were grown at 24ºC to an optical density of 0.6--0.8; expression was induced for 3 h with 0.5 mM isopropyl-β-[d]{.smallcaps}-thiogalactoside. After expression of each of the Gin4 constructs, cells were flash frozen in liquid nitrogen and then lysed using the coffee grinder method and stored at −80°C. Purification of GST-Gin4Δkinase was performed as for full-length Gin4, except that 20 mM glutathione was used for the elution. For Gin4-C, the manufacturer\'s protocol was used for purification with calmodulin affinity resin, except that the binding buffer contained 300 mM NaCl and the elution buffer contained 1 M NaCl.

### Bnr1.

The \[*GAL1,10::6His-BNR1::URA*\] 2 μ plasmid was transformed into a protease-deficient strain ([@B33]). Constructs encoding truncations of \[*GAL1,10::6His-BNR1::URA*\] 2 μ were generated by direct disruption of the plasmid in a *bnr1Δ* strain of the Research Genetics background. For expression and purification of both full-length and N-terminal Bnr1, we modified previously described protocols ([@B51]). Cultures were grown in SC-URA with 2% raffinose; cells were expanded from single colonies to 1 l over the course of 3 d. At OD~600~ 0.8, expression was induced with 2% galactose for 8 h. Cells were collected by centrifugation and flash frozen on liquid nitrogen. Cells were lysed in liquid nitrogen with a coffee grinder; powders were stored as 5-g aliquots at −80ºC. Five grams of frozen powder was slowly warmed to room temperature and resuspended in 50 ml of lysis buffer (1× PBS, 100 mM NaCl, 25 mM Tris, pH 8, 20 mM imidazole, 0.8 mM dithiothreitol \[DTT\], and 5% glycerol with 2× protease inhibitor cocktail \[Complete EDTA-free; Roche\]). The lysates were centrifuged at 60,000 rpm for 1 h at 4ºC in a Ti70 rotor. We added 0.5 ml 50% nickel-nitriloacetic acid (Ni-NTA) agarose (Qiagen, Valencia, CA) to each 5-g lysate and incubated with end-over-end rotation for 1.5--2 h at 4ºC. Ni-NTA agarose was separated by centrifugation and washed with 5× volumes with wash buffer (1× PBS, 350 mM NaCl, 25 mM Tris, pH 8, 20 mM imidazole, 0.8 mM DTT, 5% glycerol, 1× protease inhibitors). The resin was then loaded onto a disposable column (Bio-Rad, Hercules, CA) to remove any remaining wash buffer; elution buffer (1× PBS, 100 mM NaCl, 25 mM Tris, pH 8, 350 mM imidazole, 1.0 mM DTT, 5% glycerol, 1× protease inhibitors) was then added at one-half the volume of the original agarose. The buffer in the resulting fraction was exchanged for HEKG~5~ (25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\]-K, pH 7.4, 1 mM EDTA, 50 mM KCl, 5% glycerol) via Zeba desalt columns (Pierce, Rockford, IL).

Protein concentrations were estimated via SDS--PAGE gel densitometry using dilutions of bovine serum albumin as a standard. We confirmed that purified proteins were monodispersed using gel filtration chromatography with Sepharose 200 (GE Healthcare), which was run at 0.4 ml/min with HEKG~5~ buffer with 1 mM DTT.

Immunoprecipitation and pull-downs
----------------------------------

Immunoprecipitations of Bnr1-758-13myc with either anti-CBP (Millipore) or anti-HA were performed as previously described ([@B11]; [@B36]), except that the IP buffer contained 50 mM HEPES-K, pH 7.6, 1 mM ethylene glycol tetraacetic acid, 1 mM MgCl~2~, and 0.1% Tween-20 with either 75 or 150 mM KCl, as indicated.

The pull-down assay using GST-Gin4 or GST-Gin4Δkinase was performed as follows. Full-length 6His-Bnr1 was combined with GST alone, GST-Gin4, or GST-Gin4Δkinase prebound to beads and normalized for protein concentration. HEKG~5~, with a final concentration of either 75 or 150 mM KCl, was added to a final volume of 100 μl. Reactions were incubated for 1 h at 4ºC with end-over-end rotation. Beads were washed five times with 250 μl of HEKG~5~ with either 75 or 150 mM KCl. Beads were resuspended in 10 μl of 2× SDS--PAGE sample buffer (Boston Bioproducts, Ashland, MA). The samples were boiled for 5 min and centrifuged at maximum speed before loading. Similarly, full-length or Bnr1-N was combined with FLAG affinity beads with or without pCAL-n-FLAG-Gin4-C.

Homology scanning
-----------------

We used methods described previously ([@B15]) to analyze the percentage identity of sequences with a sliding window. We used the budding yeast sequence of Bnr1 as the base sequence. For the data set of sensu lato yeast, we aligned *S. cerevisiae*, *Saccharomyces bayanus*, and *Saccharomyces castelli*. For the fungal data set, we aligned *Kluyveromyces lactis*, *Candida albicans*, *Candida glabrata*, and *Ashbya gossypii*. The output of the alignment program was then copied into Excel and used to generate graphical data.
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DAD

:   Diaphanous autoregulatory domain

DID

:   Diaphanous inhibitory domain

DRF

:   Diaphanous-related formin

RBD

:   Rho-binding domain
